Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status.

Kaiho Y, Yamashita S, Ito A, Kawasaki Y, Izumi H, Kawamorita N, Adachi H, Mitsuzuka K, Arai Y

Open source

DOI: 10.4111/icu.2016.57.5.357
Published: 2016 Sep
Container: Investigative and clinical urology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4111/icu.2016.57.5.357,
  title = {Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status.},
  author = {Kaiho Y and Yamashita S and Ito A and Kawasaki Y and Izumi H and Kawamorita N and Adachi H and Mitsuzuka K and Arai Y},
  year = {2016},
  journal = {Investigative and clinical urology},
  doi = {10.4111/icu.2016.57.5.357},
  url = {https://doi.org/10.4111/icu.2016.57.5.357}
}

RIS

TY  - JOUR
TI  - Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status.
AU  - Kaiho Y
AU  - Yamashita S
AU  - Ito A
AU  - Kawasaki Y
AU  - Izumi H
AU  - Kawamorita N
AU  - Adachi H
AU  - Mitsuzuka K
AU  - Arai Y
PY  - 2016
JO  - Investigative and clinical urology
DO  - 10.4111/icu.2016.57.5.357
UR  - https://doi.org/10.4111/icu.2016.57.5.357
ER  -

APA

Y, K., S, Y., A, I., Y, K., H, I., N, K., H, A., K, M., & Y, A. (2016). Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status.. Investigative and clinical urology. https://doi.org/10.4111/icu.2016.57.5.357

Source records

pubmed · retrieved 2026-11-11T00:07:48.639Z
europe-pmc · retrieved 2026-11-11T00:07:48.653Z
doaj · retrieved 2026-11-11T00:07:48.637Z